SYNEKTIK SPÓLKA AKCYJNA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.6 PLN | -0.97% |
|
-4.81% | +42.56% |
| Sales 2024 * | 518M 128M | Sales 2025 * | 521M 129M | Capitalization | 1.05B 259M |
|---|---|---|---|---|---|
| Net income 2024 * | 73M 18.07M | Net income 2025 * | 64M 15.84M | EV / Sales 2024 * | 1.87 x |
| Net cash position 2024 * | 78.68M 19.47M | Net cash position 2025 * | 88.79M 21.97M | EV / Sales 2025 * | 1.84 x |
| P/E ratio 2024 * |
14.3
x | P/E ratio 2025 * |
13.5
x | Employees | 165 |
| Yield 2024 * |
2.8% | Yield 2025 * |
2.3% | Free-Float | 49.86% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.97% | ||
| 1 week | -4.81% | ||
| Current month | -17.99% | ||
| 1 month | -16.31% | ||
| 3 months | +41.90% | ||
| 6 months | +95.85% | ||
| Current year | +42.56% |
1 week
117.00
128.80
1 month
117.00155.00
Current year
80.80157.00
1 year
48.50157.00
3 years
22.50157.00
5 years
10.20157.00
10 years
8.56157.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01-10-03 | |
| Founder | - | 01-10-03 | |
| Director/Board Member | - | 11-01-10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 52 | 18-04-09 | |
| Director/Board Member | 58 | 17-10-15 | |
Dariusz Daniluk
BRD | Director/Board Member | 60 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 122.6 | -0.97% | 35,989 |
| 24-04-18 | 123.8 | +4.74% | 34,228 |
| 24-04-17 | 118.2 | -0.17% | 57,104 |
| 24-04-16 | 118.4 | -6.62% | 67,713 |
| 24-04-15 | 126.8 | -1.55% | 45,132 |
Delayed Quote Warsaw S.E., April 19, 2024 at 11:58 am EDT
More quotes
Synektik SA is a Poland-based company active in the medical sector. It produces PACS software which allows running a diagnostic imaging laboratory. It runs a research laboratory which performs acceptance and specialist tests of X-ray equipment. The Company sells medical equipment and operates a services center for imaging equipment. Synektik SA is a partner of Siemens. On November 28, 2013, the Company raised its stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o to 100%.
Calendar
2024-06-10
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
122.6
PLN
Average target price
119
PLN
Spread / Average Target
-2.90%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +42.56% | 258M | |
| +2.64% | 208B | |
| +1.80% | 174B | |
| +8.59% | 130B | |
| +16.47% | 98.97B | |
| -3.42% | 60.46B | |
| +12.71% | 51.73B | |
| -6.61% | 45.33B | |
| -4.53% | 38.9B | |
| +9.27% | 38.56B |
- Stock Market
- Equities
- SNT Stock
